Infectious Diseases – Products

On February 28, 2025, WHO announced the recommended strains for the 2025-2026 northern hemisphere influenza season.

Thermo Fisher Scientific introduces the Thermo Scientific™ TSX™ Core Series ULT freezers, designed to provide reliable performance and robust durability in a user-friendly solution.

On February 18, 2025, Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a twice-yearly injectable HIV-1 capsid inhibitor for pre-exposure prophylaxis (PrEP).

Revvity, Inc. (NYSE: RVTY), announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune status against measles virus.

This application note explores an innovative spectral flow cytometry method optimized for NK cell characterization.

Thermo Fisher Scientific has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for the Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel.

ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative anticancer virus platform, the SJ-600 series.

PacBio (NASDAQ: PACB), announced a significant publication from Radboud University Medical Center (Radboudumc) and its research partners in the American Journal of Human Genetics.

This application note explores how an innovative panel provides a comprehensive tool for infectious disease research and public health monitoring.

This application note explores how this advanced technology is a powerful tool for public health monitoring and viral discovery research.